相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform
Christopher Chevillard et al.
MOLECULAR THERAPY (2022)
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
Sara Feola et al.
FRONTIERS IN IMMUNOLOGY (2022)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
THE DREAM VACCINE
Jon Cohen
SCIENCE (2021)
Protein-based antigen presentation platforms for nanoparticle vaccines
Brian Nguyen et al.
NPJ VACCINES (2021)
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok et al.
IMMUNITY (2021)
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen et al.
SCIENCE (2021)
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
Joan Kha-Tu Ho et al.
VIRUSES-BASEL (2020)
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
Jerri C. Caldeira et al.
VIRUSES-BASEL (2020)
Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy
Wenyi Zhao et al.
PHARMACOGENOMICS (2020)
The Adenovirus Dodecahedron: Beyond the Platonic Story
Solene Besson et al.
VIRUSES-BASEL (2020)
Power to the protein: enhancing and combining activities using the Spy toolbox
Anthony H. Keeble et al.
CHEMICAL SCIENCE (2020)
Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display
Charles Vragniau et al.
SCIENCE ADVANCES (2019)
Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model
Cunbao Liu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
Karl D. Brune et al.
SCIENTIFIC REPORTS (2016)
Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
Rachid Ammi et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Vaccine adjuvant uses of poly-IC and derivatives
Karen Ao Martins et al.
EXPERT REVIEW OF VACCINES (2015)
Structural Analysis and Optimization of the Covalent Association between SpyCatcher and a Peptide Tag
Long Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Virus-induced humoral immunity: on how B cell responses are initiated
Franziska Zabel et al.
CURRENT OPINION IN VIROLOGY (2013)
Impact of Human Adenovirus Type 3 Dodecahedron on Host Cells and Its Potential Role in Viral Infection
Pascal Fender et al.
JOURNAL OF VIROLOGY (2012)
Functional Characterisation of the WW Minimal Domain for Delivering Therapeutic Proteins by Adenovirus Dodecahedron
Ana Villegas-Mendez et al.
PLOS ONE (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
In Vivo Delivery of Antigens by Adenovirus Dodecahedron Induces Cellular and Humoral Immune Responses to Elicit Antitumor Immunity
Ana Villegas-Mendez et al.
MOLECULAR THERAPY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Detergent binding explains anomalous SDS-PAGE migration of membrane proteins
Arianna Rath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Anti-tumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector
Olivier Epaulard et al.
MOLECULAR THERAPY (2006)
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
LL Villa et al.
LANCET ONCOLOGY (2005)
Inferences, questions and possibilities in toll-like receptor signalling
B Beutler
NATURE (2004)
Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases
R Galinier et al.
BIOCHEMISTRY (2002)
Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity
N Shibagaki et al.
JOURNAL OF IMMUNOLOGY (2002)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Antigen processing by the proteasome
PM Kloetzel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma
M Bellone et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
